Nurix Therapeutics NRIX - Options Chain | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc (NRIX) Options

Nurix Therapeutics Inc (NRIX)

9.69

-0.82

(-7.80%)

Closed April 06 3:00PM

Delayed by 15 minutes

9.5001

-0.1899

(-1.96%)

After Hours: 6:59PM

Delayed by 15 minutes

NRIX Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.10	2.85	0.00	1.475	0.00	0.00 %	0	0	-
12.50	0.05	2.55	1.10	1.30	0.00	0.00 %	0	2	-
15.00	0.00	5.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	0.05	0.70	0.05	0.375	-0.03	-37.50 %	1	61	4/04/2025
20.00	0.60	2.00	0.60	1.30	0.00	0.00 %	0	188	-
22.50	0.53	5.00	0.53	2.765	0.00	0.00 %	0	90	-
25.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
35.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
5.00	0.00	0.05	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
17.50	6.10	10.50	2.05	8.30	0.00	0.00 %	0	51	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	10.50	15.00	6.00	12.75	0.00	0.00 %	0	10	-
25.00	13.00	18.00	6.60	15.50	0.00	0.00 %	0	2	-
30.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
35.00	23.00	28.00	0.00	25.50	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AREBAmerican Rebel Holdings Inc	US$ 19.50 (392.42%)	83.21M
AEHLAntelope Enterprise Holdings Ltd	US$ 4.20 (100.00%)	11.16M
CXAICXApp Inc	US$ 1.4108 (74.86%)	92.26M
XHGXChange TED Inc	US$ 1.11 (50.00%)	2.99M
WCTWellchange Holdings Company Limited	US$ 0.279 (43.08%)	208.11M
SZZLUSizzle Acquisition Corporation II	US$ 9.99 (-52.16%)	667.76k
VRPXVirpax Pharmaceuticals Inc	US$ 0.35 (-47.72%)	187.6k
NMTCNeuroOne Medical Technologies Corporation	US$ 0.48 (-44.19%)	2.02M
SONMSonim Technologies Inc	US$ 1.80 (-32.58%)	2.14M
PRPHProPhase Labs Inc	US$ 0.24 (-30.64%)	3.48M
NVDANVIDIA Corporation	US$ 94.31 (-7.36%)	532.11M
MULNMullen Automotive Inc	US$ 0.0775 (-2.52%)	368.33M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7.9301 (-20.94%)	344.3M
DMNDamon Inc	US$ 0.0135 (-10.60%)	293.03M
TQQQProShares UltraPro QQQ	US$ 41.09 (-18.31%)	258.03M

Monksdream

Monksdream 6 months ago

NRIX 10Q due Oct 17

Monksdream

Monksdream 6 months ago

NRIX 10 Q due 10 October

Monksdream

Monksdream 7 months ago

NRIX creeping higher

Monksdream

Monksdream 9 months ago

NRIX 10 Q expected JULY11

Monksdream

Monksdream 9 months ago

NRIX new 52 week high

Monksdream

Monksdream 10 months ago

NRIX more new highs up ahead

Monksdream

Monksdream 12 months ago

Monksdream

Monksdream 12 months ago

Monksdream

Monksdream 1 year ago

NRIX new 52 week high

TheFinalCD

TheFinalCD 3 years ago

https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/88898489/cathie-wood-doubles-down-on-these-2-strong-buy

infamous

infamous 4 years ago

what the F is wrong with this fkn stock? does it ever go up???

Phosphene

Phosphene 4 years ago

CEO: Dr. Arthur T. Sands

https://www.nurixtx.com/arthur-t-sands-m-d-ph-d/

Phosphene

Phosphene 4 years ago

Strategic partnerships with Sanofi and Gilead Sciences Inc.

https://www.nurixtx.com/research-development/strategic-partnerships/

Wellington and Baker Brothers are among Institutional Ownership and Shareholders:

https://fintel.io/so/us/nrix?__cf_chl_jschl_tk__=c9a7439112376e9f70de91c1316dfcc7e26d3519-1607403189-0-AT-0XpHMlNGWmcEzimwDKelDxLnOK6gsd8IihalGD8DcDe76KQlrWnh2Q1G3OLjfsidXSQyjVOkcCg3lXIXgKu6RIlw8DMusjRJpgnTzQP2qkahd1WSCP-5At2BI9Udfzc2vqpmlZOV3prAMIdFIh1_urJuBNq7hGlM4oSEJKFEFs8WDerUagukeDe9yBmvVg0Ne17vR8ByRaN-BlyHHxPWeTerJ_ZHoD1jnsxFYInhjhkK-XNkhe3BJ0Wzq3782kDVndNMNsb1glMkmm_NlSnc8Xbwve1nF3nGShcpgUxA-nefEgd9L74SzGXF1WftTIX4HYgwtb1BRzq82RClNfm9dr9Xb-hKp3xKKiYL4k9KfqV9OAePxDJoYgKqLUziXoA

Phosphene

Phosphene 4 years ago

Data support a planned clinical trial of NX-2127 in B-cell malignancies

http://www.globenewswire.com/news-release/2020/12/07/2140737/0/en/Nurix-Therapeutics-Presents-Preclinical-Data-at-62nd-American-Society-of-Hematology-ASH-Annual-Meeting-and-Exposition.html

Nurix Therapeutics

Westwing Comercio Vareji...

Kora Saude Participacoes...

Clover Health Investments

Alianza Urban Hub Renda ...

CELULOSE IRANI ON

Brazilian Graveyard Deat...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions